Neurophet-AriBio to develop ‘Next-Gen Platform for Alzheimer’s diagnosis’
Neurophet’s brain MRI analysis technology incorporates fluid biomarker data from AriBio’s global Phase 3 clinical trial for Alzheimer’s disease Collaborates leveraging Neurophet’s medical image analysis technology and AriBio’s clinical trial data analysis expertise Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its collaboration with AriBio, a biopharmaceutical company developing therapies for neurodegenerative […]